Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.100
+0.040 (3.77%)
At close: Dec 10, 2025, 4:00 PM EST
1.130
+0.030 (2.73%)
After-hours: Dec 10, 2025, 6:42 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $5.95 million as of December 10, 2025. Its market cap has decreased by -51.78% in one year.
Market Cap
5.95M
Enterprise Value
7.14M
1-Year Change
-51.78%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $5.95M, a decrease of -89.83%. That is a compound annual growth rate of -42.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 5.74M | -60.58% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |